🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We are happy to announce the IBUS endorsed Congress in Milan, Italy in collaboration with the San Raffaele Hospital. Scientific Directors of this event are Dr Mariangela Allocca, Dr Emma Calabrese, and Prof. David Rubin. More Information: ibus-group.org/event/endorsed… #IBUS #IUS #IBD

The 7th Stelara biosimilar has been FDA approved! Ustekinumab-stba (Steqeyma; Celltrion) is expected to launch 02/2025! 🎉 #Biosimilar #IBD #GITwitter -45 mg/0.5 mL or 90 mg/1 mL prefilled syringe -130 mg/26 mL intravenous infusion pharmacytimes.com/view/ustekinum…

🌟 𝗡𝘂𝗺𝗯𝗲𝗿 7🌟 🔬🧒 Antibiotics, passive smoking, high SES, sugary foods, and urban living ⬆️pediatric #IBD risk. Pet exposure & more siblings lower the risk. #Pediatrics Nisha Thacker APD Kerith Duncanson Emily Hoedt Laureate Prof Clare Collins AO onlinelibrary.wiley.com/doi/10.1002/jp…

Use of Biosimilars to Infliximab During Pregnancy in Women... : Clinical and Translational Gastroenterology journals.lww.com/ctg/fulltext/2…

Striking the Right Balance for Eligibility Criteria for Clinical Trials in Inflammatory Bowel Disease UEGJ Virginia Solitano Vipul Jairath MBChB DPhil Silvio Danese onlinelibrary.wiley.com/doi/full/10.10…

25-year-old man with ileocolonic penetrating Crohn’s disease presents to ER with severe right sided abdominal pain and fevers for two weeks. #caseofthemonth #Crohns #IBUS #IUS

VEDOKIDS Maintenance treatment with vedolizumab in paediatric inflammatory bowel disease just published ✅ At w54 47% UC/IBDU in clinical remission and 24% of CD 🌟 The importance of having these studies to prove safety & efficacy in pediatric population is paramount

Wound Healing After Vaginal Delivery, Episiotomy, and Cesarean Section Delivery Among Women With IBD: Results From the PIANO Registry IBDJournal & CC360 academic.oup.com/ibdjournal/art…

EOSINOPHILS in IBD? Our work in #JCC suggests anti-IL-12/23 may be more effective in managing eosinophil-associated inflammation in IBD. Eosinophil reduction was identified as a marker of early response to ustekinumab in both UC/CD, but not adalimumab or vedolizumab. Link below

February 12: IBD Educational Program for Patients - mailchi.mp/uchicago/uchic…

We had a vote for the best IBD papers in 2024 during our webinar "Best of 2024" KIWI (医療従事者へ向けたIBD教育企画)

Such a HUGE win for the #IBD community. Stay tuned for an article on Lights, Camera, Crohn's TOMORROW about the inspiration behind the resource and how it can benefit patients/caregivers/healthcare providers alike! #crohns #colitis

Vedolizumab & ustekinumab appear effective & safe in pediatric IBD up to 52 weeks: 36–49% steroid-free remission at Week 14 & >50% at Week 52. #Pediatrics #IBD onlinelibrary.wiley.com/doi/10.1002/jp… onlinelibrary.wiley.com/doi/10.1002/jp…

Higher Rates of Delay in Starting Advanced Inflammatory... : Clinical and Translational Gastroenterology journals.lww.com/ctg/fulltext/9…

A monumental day, first Module 1 at the Crohn’s & Colitis Congress executed by iUSCAN in partnership with Gastroenterology and Crohn's & Colitis Foundation directed by Rishika Chugh at UCSF

1st intestinal ultrasound training at a North American IBD Conference is complete! Incredible day and could not have happened without the support and work from Crohn's & Colitis Foundation American Gastroenterological Association (AGA) InternationalBowelUS iUSCAN collaborating together.

Curious about #intestinalultrasound? Then don't miss our latest episode with Michael Todd Dolinger, MD MBA talking to Jason Silverman and Temara Hajjat, MD, covering: 💪🏻 Strengths of IUS 🎓 How to get certified 🏥 Integrating it into your practice 🎧👉 buzzsprout.com/581062/episode…

InternationalBowelUS president shares IMPRESSIVE Growth 📈with IUS central reading now in 8 clinical trials! ⭐️#krisztinagecse Christian Kerri Mariangela Allocca Rune Wilkens iUSCAN

InternationalBowelUS IBUS get together meeting at #ECCO2025. A huge turn out and the society is growing exponentially. A huge congratulations to Frauke Petersen for receiving IBUS #honorary member award. Her dedication on #IUS is a true inspiration. Also wanted to take an opportunity

Valuable updates to the ECCO-ESPGHAN guideline on management of ASUC in Pediatric patients! Eytan Wine #ECCO2025